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Lactose intolerance 
 
Introduction 
Lactose is a carbohydrate found mostly in dairy products: it is a disaccharide, and is composed of 
galactose and glucose. For a simple sugar, lactose is rather unusual, as it is less sweet to taste and 
less water soluble than would normally be predicated.  Lactose is digested to its component 
monosaccharides by the enzyme lactase. Lactase is a brush-border enzyme, which is synthesised by 
the cells lining the small bowel, and released onto the outside of the plasma membrane; the enzyme 
works at the cell surface, immediately prior to the absorption of the monosaccharides. If this enzyme 
is deficient or absent altogether, then lactose intolerance occurs. This is quite different from an 
allergy to lactose (or milk). Such an allergy would be a disorder of the immune response, and 
represent a significant, systemic disease. Furthermore it is possible that many people wrongly 
diagnose themselves as allergic or intolerant to milk, and try to control this by denying themselves 
milk and other dairy products (NHS Choices 2011). Such people are unnecessarily missing out on an 
important and nourishing food. For this reason if lactose intolerance is suspected, it should be 
carefully investigated and diagnosed, prior to the introduction of dietary management. 
Types of lactase deficiency  
Primary lactase deficiency is the most common type of lactose intolerance (NHS Choices 2011), 
accounting for 70% of all sufferers (BMJ Best practice). Lactase production decreases in the young 
child as they become less dependent upon milk in their diet, at around the age of two or three years, 
although problems may not become apparent until adulthood. It is largely genetically controlled. An 
individual’s response to lactose can thus be classified as lactase persistent (LP), who are able to 
digest lactose; and lactase non-persistent (LNP) who are not able to digest lactase, and thus 
experience lactose intolerance (Shrier et al 2008). 
As a general rule, populations who trace their origins to equatorial regions and in the East tend to be 
more prone to lactose intolerance than those from the Polar Regions (Shrier et al 2008). The 
traditional explanation for this was that individuals living in those regions where the population was 
dependent upon milk in the diet would experience a severe disadvantage in being lactose intolerant, 
so that the gene was discouraged. However, populations from polar regions were at risk of vitamin D 
deficiency, and being able to consume and digest milk may have made calcium available, thus off-
setting a deficiency in vitamin D. It has been suggested more recently that the gene for a lack of 
lactose could also have protected populations from malaria (Shrier et al 2008).   
Secondary lactose deficiency is when another condition causes a reduction in the availability of 
lactase. Such conditions include Crohns disease, gastroenteritis and surgery, and it can also occur as 
a complication of anti cancer drugs. In these cases the lactose deficiency may be temporary, but it 
can also be permanent.  
Congenital lactase deficiency is present from birth. It is extremely rare; only 40 cases have ever been 
reported world-wide. Familial lactase deficiency is similar but in this case the lactase is released but 
does not have the expected effect. Both are inherited autosomal recessive conditions – that is to say 
that both genes need to be affected for the individual to suffer from the condition. 
Developmental hypolactasia sometimes occurs in the premature infant (less than 34 weeks) and 
improves rapidly as the infant matures. It has further been suggested (Kanabar et al 2001) that 
transient lactose intolerance is the cause of infant colic in some cases. 
Genetics of lactase deficiency  
The gene for lactase production is located on the long arm of chromosome 2. Alterations in the 
promoter region of this gene can lead to LNP. The promoter region is that part of the chromosome 
that enables the gene itself to function. In LNP people alterations appear that reduce or eliminate 
the gene’s ability to synthesise lactase. These alterations are recessive, which means that the person 
has to be homozygous for LNP in order to develop lactose intolerance. Furthermore, the alteration 
can be complete, so that the person does not produce any lactase (anlactasia), or incomplete 
(hypolactasia), which means that they do not synthesise lactase in the usual quantities. The amount 
of lactase present will directly influence how intolerant they are to lactose. 
The numbers of people affected varies greatly around the world: about 5-15% of people of northern 
European origin are affected, and in these people LNP tends to occur later, whilst in African 
American and Asians LNP is almost universal and occurs from a few months old (BMJ Best practice). 
Overall 70% of the world’s population are LNP, and this may be the “natural state” (Roxas 2008), 
with LP developing later, as populations migrated. 
Effects of lactase deficiency 
When an LNP individual takes in significant quantities of milk, they are unable to digest the lactose. 
This disaccharide then passes, unaltered, into the large bowel, where there are two possible 
outcomes. 
1. This disaccharide in the gut is osmotically active, and attracts water into the large bowel, 
causing the LNP person to experience abdominal cramps and diarrhoea. 
2. The lactose is fermented by the micro-organisms that normally inhabit the gut. The result of 
this fermentation is short chain fatty acids, carbon dioxide, hydrogen and methane. This is 
often perceived as mitigating the effects of LND (Shrier et al 2008), but it is also possible 
that these gasses that cause people uncomfortable feelings of being “bloated” and passing 
unacceptable quantities of flatus.  
Individuals who are LNP can, in fact, tolerate some milk; the amount they can manage is very 
individual, and is best worked out on a case-by-case basis. It is important to stress that a person who 
is LNP taking milk may experience unpleasant and unacceptable symptoms, but they are not in 
danger: the symptoms will wear off as the lactose passes through or is fermented. Furthermore, milk 
is a useful food, and it is worth discovering how much an individual can tolerate, rather than just 
excluding it from the diet “just to be sure”. It is also important to note that many dairy products, for 
example cheese, butter and yoghurt have minimal quantities of lactose remaining in them, and can 
be consumed without risk of any discomfort. 
Diagnosing lactose intolerance 
The simplest diagnostic test is to avoid lactose in the diet, which should lead to an improvement in 
their condition, which deteriorates again when the lactose is re-introduced. However, this is quite a 
subjective test, and the diagnostic test of choice is the lactose hydrogen breath test. The patient is 
fasted then given an oral load of lactose and then a breath test for hydrogen is conducted at regular 
intervals over the next two or three hours. Hydrogen is a by-product of colonic anaerobic bacteria 
acting on un-digested dietary carbohydrate. This hydrogen is released into the lumen of the bowel 
and is absorbed into the bloodstream to be excreted in the lungs: a value of over 20 parts per million 
is suggestive or LNP, and a value of 10-20ppm is non-determinate, and needs to be interpreted in 
view of the presence of symptoms (Roxas 2008). A false negative result can be obtained if the 
person has recently had oral antibiotics, which will have killed the relevant organisms, and in some 
people who are resistant to producing hydrogen (BMJ Best practice). False positives can be obtained 
when bacterial overgrowth has occurred into the small bowel, and indeed the hydrogen breath test 
is sometimes used to test for this. Raised hydrogen has been found in some infants severely affected 
by colic (Kanabar et al 2001). 
Control of symptoms 
Treatment is only required in the presence of symptoms – asymptomatic people should not receive 
treatment. The mainstay of treatment is to exclude lactose from the diet; this mainly means milk and 
cream. Cheese and yoghurts can cause symptoms but often do not, as they have less lactose 
present. Lactose is usually only found in milk and milk products, but it can be incorporated into some 
prepared meals, particularly foods sold to dieters. People who find they need to exclude all dairy 
products may need nutritional advice to ensure they obtain all the nutrients they need, particularly 
Calcium and vitamin D. People who continue to experience symptoms despite apparently 
eliminating lactose from their diet may also need nutritional advice to help locate any “hidden 
lactose” (BMJ Best practice). Lactose- free milks, such as soya milk are also commercially available.  
Some foods have been pre-treated with lactase, but the evidence of the effectiveness of these in 
controlling symptoms is unclear (BMJ best practice). However, oral lactase supplementation has 
been shown to allow even people who are severely LNP to take milk and dairy products without 
discomfort. A double-blind, placebo controlled trial involved giving babies who were badly affected 
by colic some lactase, either mixed with the formula milk or after a breast feed. The results of this 
research was adversely affected by poor compliance to the lactase regime, but some of those babies 
who experienced severe colic and received lactase cried less and had less hydrogen on their breath 
than those who received a placebo, but some did not respond. The authors conclude that lactose 
intolerance is the cause of severe colic in some babies, but others experience colic for other reasons 
(Kanabar et al 2001). 
Conclusion 
Lactose intolerance is a very common complaint; it leads to a number of distressing symptoms in 
those affected. It can be quite easy to control by reducing milk in the diet, and possibly by adding 
lactase to the diet.  However, particularly in the indigenous white population we should be wary of 
over-diagnosing this condition, and thereby depriving the individual of a useful, cheap and nutritious 
food. 
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